We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, has appointed Juan Carlos Jaramillo, MD as chief medical officer and member of the Management Board starting October 1, 2020.